Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Synopsys Inc (NQ: SNPS )

520.66 -6.92 (-1.31%)
Streaming Delayed Price Updated: 12:11 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Synopsys Inc

Synopsys Inc. (NASDAQ: SNPS) Making Surprising Moves in Thursday Session
Via Investor Brand Network
Wall Street is surprisingly most bullish on these 3 Nasdaq stocks
Analysts are gradually shifting toward underperforming, less prominent names to find the next big thing - including these three current Wall Street faves 
Via MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Karuna Therapeutics, Inc. (Nasdaq – KRTX), Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)
From Brodsky & Smith LLC
Via GlobeNewswire
Synopsys Inc. (NASDAQ:SNPS) Records 52-Week High Thursday Morning
Via Investor Brand Network
Synopsys Inc. (NASDAQ: SNPS) Highlighted for Surprising Price Action
Via Investor Brand Network
Synopsys Inc. (NASDAQ: SNPS) is a Leading Gainer in 5/25 Morning Trading
Via Investor Brand Network
These 5 growth stocks are now in buy ranges
Affirm, MongoDB, UIPath, Synopsys and Crispr's charts signal buy opportunities as these top-performing tech and biotech stocks consolidate below prior highs. 
Via MarketBeat
Topics ETFs
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Karuna Therapeutics, Inc. (Nasdaq – KRTX), Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)
From Brodsky & Smith LLC
Via GlobeNewswire
AstraZeneca: Rebound in 2024 with double-digit earnings growth
AstraZeneca's stock rose 8.95% in the past month on a bullish outlook, driven by growing sales of cancer and diabetes drugs and a strategic acquisition 
Via MarketBeat
Exposures COVID-19
Synopsys stock: Unsung hero of the AI revolution
Synopsis, the leading provider of electronic design automation software, is up more than 60% in 2023 as customers AMD, Nvidia and Intel expand AI capabilities. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Synopsys offers to acquire Ansys, sparks stock surge
Ansys stock rose 18% on Synopsys acquisition news. Fellow engineering software maker Altair also rose on speculation it may be an acquisition target. 
Via MarketBeat
Keysight, Synopsys, and Ansys Accelerate RFIC Semiconductor Design with New Reference Flow for TSMC’s Advanced 4nm RF FinFET Process
From Keysight Technologies, Inc.
Via Business Wire
3 Reasons Unity Software Is Ready to Rally 38%
Unity Software nabbed a "buy" upgrade from Bank of America, shedding light on the software developer's untapped potential. Analysts expect EPS to grow by 79%. 
Via MarketBeat
3 Smart AI ETFs For Intelligent Passive Investing Needs
These AI ETFs can benefit from a multi-trillion growth opportunity that is in the early innings and has years to run for investors. 
Via MarketBeat
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
Intel and Synopsys Expand Partnership to Enable Leading IP on Intel Advanced Process Nodes
From Intel Corporation
Via Business Wire
AI Design Sends Synopsys, Nvidia, TSMC & Other Chip Stocks Higher
Synopsys.ai, a suite of AI-driven solutions for the chip industry, can accelerate chip performance while saving time and cutting manufacturing costs. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Is Chip Design Specialist Synopsys A Gem Hiding In Plain Sight?
Chip design software maker Synopsys has been consolidating since February. Its technical and fundamental strength suggests it may be ready to notch more gains. 
Via MarketBeat
SiFive and Synopsys Collaborate to Accelerate SoC Design
From SiFive
Via Business Wire
NASDAQ:SNPS Investor Alert: Investigation over Potential Wrongdoing at Synopsys, Inc.
San Diego, CA -- (SBWIRE) -- 08/10/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Synopsys, Inc. 
Via SBWire
NASDAQ: SNPS Investor Notice: Investigation over Possible Securities Laws Violations by Synopsys, Inc.
San Diego, CA -- (SBWIRE) -- 04/26/2022 -- An investigation for investors in Synopsys, Inc. (NASDAQ: SNPS) shares over potential securities laws violations by Synopsys, Inc. was announced. 
Via SBWire
SYNOPSYS ALERT: Bragar Eagel & Squire, P.C. is Investigating Synopsys, Inc. on Behalf of Synopsys Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
SYNOPSYS ALERT: Bragar Eagel & Squire, P.C. is Investigating Synopsys, Inc. on Behalf of Synopsys Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Synopsys, Inc. (SNPS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Synopsys, Inc. (SNPS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Synopsys, Inc. (SNPS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.